A. R. Gibson-c and G. J. Mc, Determination of 3-methoxy4 hydroryphenylethylene glycol in urine by liquid chromatography with amperometric detection, Life Sci, vol.29, pp.1689-1696, 1981.

A. M. Bertilsson-l and T. D. , Indolamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline, 1973.

A. M. Traskman-l and . Thoren-p, S-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch, Gen. Psychiatry, vol.33, pp.1193-1197, 1976.

B. J. Rafaelsen-o, Echelles d'anxieté, de manie, de dépression, de schizophrénie. Correspondance avec les syndromes du DSM lll (traduit de l'anglais par Chambon O, Poncet F, Kiss L) Collection Médecine et Psychothérapie, 1989.

B. H. Goodwn-f, Antidepressant response to tricyclics and urinary MHPG in unipolar patients, 1975.

B. H. Goodwln and F. K. , (i980). urinary MHPG in subgroups of depressed patients and normal controls, pp.91-100

B. P. Heel-r and L. S. , Fluoxetine, a review of its pharmacologic and parmacokinetics properties and therapeutic efficacity in depressive illness. Drugs, pp.481-508, 1986.

B. P. Galateo-e and . Valzelli-l, Fluoxetine activity on muricidaf agression induced in rats by p-chlorophenylalanine, Agressfue Behav, vol.9, pp.333-338, 1983.

B. P. De-montigny-c and . Chaput, (i988) Détermination électrophysiologique de l'effet des traitements antidépresseurs sur l'efficacité de la neurotransmission sérotoninergique, Clin. Neuropharmacol, vol.1, issue.1, pp.1-51

J. Barchas and J. , Catecholamines-basic and clinical frontiers, pp.213-215

J. G. Tissot-r, Gontribution à l'étude du MHPG plasmatique, marqueur noradrénergique périphérique et des taux plasmatiques hormonaux de cortisol,T3, T4, TSH, dans les syndromes dépressrts, pp.203-211, 1991.

B. K. Skjelbo-e, Fluoxetine and norfluoxetine are potent inhibitors of P450llD6 -the source of the sparteine/debrisoquine oxidation polymorphism, Br. J. CIin. Pharmacol, vol.32, pp.136-137, 1991.

B. N. Barbaccia-m, C. D. , and C. E. , Down regulation of p-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons. Neuropharmacology, pp.1145-1149, 1982.

B. D. Fucek-f and . P. Domino-e, Anatysis of urinary 3-methoxy-4-hydroxyphényléthylene glycol by high-performance liquid chromatography with amperometric detection, J. Chromatogr. B, vol.162, pp.394-400, 1979.

B. F. Wong-d, Effect of Lilly 110140,3-(ptrifluoro methylphenory)-N-methyl-3-phenylpropanolamine, on synthesis of 3H-serotonin from 3H-tryptophan in rat brain. The pharmacologist 16, p.244, 1977.

C. S. , C. M. Fracasso-c, and G. S. , Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norffuoxetine in the rat, 1990.

C. P. Dolera-m and A. F. Alvarez-e, Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement, J. Affect, 1992.

R. E. Clerc-c and . J. Verdeau-pa|lles, A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia, International Clinical Psychopharmacology, vol.9, issue.3, pp.139-143, 1994.
DOI : 10.1097/00004850-199409000-00001

C. J. Wilcox-c, A comparaison of fluoxetine, imipramine, and pfacebo in patients with major depressive disorder, J. Clin. Psychiatry, vol.46, pp.26-31, 1985.

D. H. Maas-j, An improved procedure of, 1970.

D. H. Maas-j, 3-methoxy-4-hydroryphenylethylene glycol in plasma, Clin. Chim. Acta, vol.52, pp.203-210, 19741.

D. T. Benkelfat-c and . Touitou-y, Lack of circadian rhythm in healthy plasma levels of 3, 1986.

P. Seminaire-de and . Biologique, Hôpital St Anne 3, pp.77-113

D. A. Tang-s, Manipulations of synaptic serotonin: discrepancy of effects on serotonin 51 and 52 sites, Life Sci, vol.32, pp.2677-2684, 1983.

E. P. Binkhuyzen-d and . Thieme-re, Direct determination of 3-methory4-sulphonyl-oryphenylglycol (MHPG sulphate) in urine using gas{iquid chromatography, J. Chromatogr, vol.3, issue.5, p.438441, 19841.

E. N. , F. E. Achaire, . Lestra-c, . Broyer-c, C. 8. Zaidan-r et al., Platelet serotonin content and free and total pfasma tryptophan in healthy volunteers during 24 hours, Clin. Chem, vol.390, pp.2337-2360, 1993.

F. L. Crismon-l, Efficacy of fluoxetine in out-patients with major depression, Curr. Ther. Res. Clin. Exp, vol.37, pp.115-123, 1985.

F. J. Maas-j and . Dekirmenjian-h, Depression and MHPG excretion, Arch. Gen. Psychiatry, vol.26, pp.246-251, 1972.

F. J. Koch-s, . Fischer-m, and . E. Muller-w, Determination of urinary 3-methoxy-4-hydroryphenylethylene glycol and its conjugates by HPLC with electrochemical and ultraviolet absorbance detection, J. Chromatogr. B, vol.493, pp.275-286

F. J. Cherkin-a, Fluoxetine enhances memory processing in mice, Psychopharmacology, vol.93, pp.36-43, 1987.

F. R. , P. K. Molloy, and B. B. , Effect on an uptake inhibitor on serotonin metabolism in rat brain: studies with, p.3, 1974.

F. R. Snoddy-h and . B. Molloy-b, Potentiation of the L-5- hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake, Res. Commun. Chem. Path, vol.10, pp.193-196, 1975.

F. Rw and . T. Wong-d, Inhibiton of serotonin re-uptake. Féd, Proc, 1977.

F. R. Snoddy-h, Effect of serotonin-releasing drugs on serum corticosterone concentration in rats, Neuroendocrinology, vol.31, pp.96-100, 0195.

F. Rw and O. J. , Suppression of milk drinking by the combination of fluoxetine and L-S-hydroxytryptophan in rats, Res. Commun. Chem, 1981.

F. R. Snoddy-h, Role of norfluoxetine in the inhibition of desipramine metabolism and in the inhibition of serotonin uptake after fluoxetine administration to rats, Res. Commun. Chem. Pathol. Pharmacol, vol.73, p.3140, 1991.

G. M. Noyes-r and C. B. Jr, Comparaison of panic disordered patients with high versus low MHPG, J. Affect. Disord, vol.20, pp.7-12, 1990.

G. M. and D. W. Mandell-a, Fading: a new cytofluorimetric measure quantifying serotonin in the presence of catecholamines at the cellular fevef in brain, J. Pharmacol. Exp. Ther, vol.2, issue.7, p.6504167, 1978.

G. X. Mc and B. W. , Selective action of fluoxetine on the extracelfufar pool of serotonin in the nucleus accumbeus. Sociefy for Neurosclêncre Aôsfracfs, p.428, 1986.

H. P. Daleskog-m and . Eltasson-k, A comparison of noradrenaline, MHPG and VMA in plasma as indicators of sympathetic nerve activity in man, Acta Physiol. Scand, vol.115, pp.507-509, 1982.

H. J. Wong-d, Effects of serotonin uptake inhibitor, Lilly 11O14O, on transport of serotonin in rat and human blood platelets, Biochem. Pharmacol, vol.25, pp.865-67, 1976.

H. E. Magnussen-1 and . H. Van-woert-m, Effects of chronic fluoxetine administration on serotonin metabolism, Res. Commun. Chem. Pharmaae\, vol.29, pp.79-98, 1980.

J. M. Bowden-c and . W. Maas-j, 3-methory4- hydroxyphenylglycol, 5 hydroryindolacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed phase HPLC and coulometric detection using 3-methory-4-hydroryphenyllactic acid as an intemal standard, J. Chromatogr. B, vol.336, pp.259-269, 0197.

J. M. Kadam-8 and R. D. , Simple HPLC method for the concurrent determination of the amine: metabolites vanillylmandelic acid, 3-methory4- hydroxyphenylglycol, S-hydroxyindolacetic acid, dihydroxyphenylacetic acid and homovanillic acid in urine using electrochemical detection, J. Chromatogr. B, vol.226, pp.361-368, 1981.

K. F. Lefevre-h, . 8. Bigelow-l, and . Gosta-e, Urinary excretion of 3-methoxy-4-hydroryphenylglycol and 3-methoxy4-hydroxyphenylethanol in man and rat, Clin. Chim. Acta, vol.43, p.127, 0198.

K. F. Moyer-schwing, S. G. Potktn, and R. J. Vttyatt, Presence of free, sulfate and glucuronide conjugated 3-methoxy4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma, Brain Res, vol.125, pp.333-339, 19771.

K. M. Perry-p, H. S. , and M. H. , Serum fluoxetine and norfluoxetine concentrations and antidepressant response, Ther. Drug Monit, vol.11, pp.165-170, 1989.

K. H. Gurbani-n and D. P. , Effects of ffuoxetine on a specific serotonergic syndrome in rats, lndian J Med. Res, vol.73, pp.653-657, 1981.

K. P. Bruntlett-c and . E. Shoup-r, Neurochemical applications of liquid chromatography with electrochemical detection, Lffe Sci, vol.28, pp.455-465, 1981.

. Larue, Flammarion Médecine-Sciences éd

L. Lilly and F. , Prozac 20mg: Chlorhydrate de fluoxétine. Dossier réservé aux pharmaciens des établissements hospitaliers. lnformation préliminaire, 1989.

L. R. , J. R. , V. M. Bougerol-t, and S. J. , Transports membranaires érythrocytaires de la tyrosine et du tryptophane et taux plasmatique de MHPG dans les dépressions. L'Encéphale, pp.269-74, 1990.

L. Fur and G. , Mécanisme d'action des antidépresseurs. Entretiens du vendredi. Conférence à I'Hôpital Saint Anne; Paris; 9 janvier, 1981.

B. F. Wong-d, Fluoxetine; a selective serotonin uptake inhibitor, 1978.

L. M. Dlmasclo and A. F. Killam-k, Psychopharmacology: A generation of progress, 1978.

L. H. Loo-p, La dépression, N"2579, Que sais-je, 1991.

L. and I. J. Jr, lmplication de la sérotonine au cours de divers troubfes psychiatriques et sur certains comportements, Br. J. Psychiatr, vol.153, p.2842, 1988.

L. S. Ll and E. T. , Effects of repeated administration of serotonergic agonists on diet selection and body weight in rats, Pharmacol. Biochem. Behav, vol.38, pp.495-500, 0200.

M. J. Dekirmenjian-h and . Fawcett-j, Catecholamine metabolism, depression and stress. Narure, pp.330-331, 19711.

M. D. Lahr-p and . R. Bosin-t, Determination of serotonin, its precursors, metabolites and t3Hl serotonin in lung by high-performance liquid chromatography with fluorescence detection, J. Chromatwr. B, pp.225-246, 1981.

M. J. Skuza and . Sowinska-h, The effect of setective inhibitors of noradrenaline and serotonin uptake on reserpine and apomorphine induced hypothermia in mice, Pol. J. Pharmacol. pharm, vol.3, pp.49-56, 1983.

M. F. Aldegunde-m, Simple HPLC with etectrochemical detection for the determination of indolamines in tissue and plasma, J. Chromatogr. B, vol.491, pp.221-225, 1989.

M. F. Rozas-g.-'miguez-j and A. M. , Plasma serotonin: factors affecting its levels, Biogenic Amines, vol.7, issue.1, pp.57-59, 1990.

L. M. Mcintyre and N. T. , Platelet serotonin response to treatment in geriatric depression, Biological Psychiatry, vol.26, issue.4, p.491496, 1989.
DOI : 10.1016/0006-3223(89)90064-4

M. R. Fisher-l, . Phebus-l, and . D. Lytle-l, Interaction of diet and drugs in the regulation of brain S-hydroryindoles and the response to painful efectric shock, Life Sci, vol.18, pp.707-714, 1976.

M. P. Borstrok-j, Analysis of urinary 3-methoxy-4- hydroxyphenylglycol by high performance liquid chromatography and electrochemical detection, J. Chromatogr. B, vol.227, p.391405, 1982.

M. V. and G. S. Mandel-p, Effects of serotonin-mimetic drugs on mouse-killing behavior, Agressfue Behavior, vol.12, pp.201-211, 1986.

M. G. , D. A. Lauro, and . P. Giannini-c, Urinary MHPG and major affective disorders. A replication and new findings Psychiatry, Arch. Gener, vol.41, pp.337-339

M. F. and J. H. Thomasson-c, Deuteration of catecholamines, catecholamine metabolites and tryptophan metabolites, J. Labelled Compd, vol.14, pp.497-505, 1978.

N. J. Mazure-g, . B. Bowers-m, and J. P. Jr, A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression, Arch. Gen. Psychiatry, vol.48, pp.303-307, 1991.

O. K. , K. K. , and T. A. Nagatsu-t, An integrated scheme for the simultaneous determination of biogenics amines, precursor amino acids, and related metabolites by liquid chromatography with electrochemical detection, J, 1984.

O. J. Martinez-e and A. F. Gelpi-e, Rapid non-enzymatic HPLC determination of total MHPG in human plasma, Sa, vol.46, pp.239-246, 1989.

O. M. Nemeroff-c, Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter, Clin Chem, vol.40, pp.288-295, 1994.

P. Plchor, J. J. Melsch, and J. R. Botsster, Action antidépressive du L-5-hydroxy-tryptophane et, 1926.

P. D. , S. D. Maas-j, and . R. Heninger-g, Primary affective disorder, clinical state change and MHPG excretion, Arch. Gener. Psychiat, vol.30, pp.234-239, 19741.

O. K. Kondo-n and . Ohara-k, Diurnal variations of whole serotonin content in patients with depression and neurosis, J. Neurol. Neurosurg. Psychiat, p.55, 1992.

P. J. Halaris-a, Gas-liquid chromatographic method for routine detection of plasma sulfo, pp.3-4, 1989.

R. A. Schatzberg-a, MHpG as a predictor of antidepressant response to imipramine and maprotiline, Am. J. Psychiatry, vol.1379, pp.1-090, 1980.

S. M. and C. P. Martinu-e, Decreased plasma serotonin in melancholic patients: a study with clomipramine, Biol Psychol, vol.22, pp.1429-1438, 1987.

S. S. Leroy-biank-c and W. D. Sczupak-c, Liquid chromatography determination of serotonin in serum and plasma, Clin. Chem. i, vol.2, pp.1509-1514, 1978.

G. J. and C. J. Rohde-w, Toward a biochemical classification of depressive disorders. l/ Differences in urinary excretion of MHPG and other catecholamine metabolites in clinicalfy defined subtypes of depressions, Arch. Gen. Psychiatr, vol.35, pp.1427-1433, 1978.

S. M. Fuller-r and . T. Wong-d, La fluoxétine, un inhibiteur hautement sélectif de la recapture de la sérotonine, 1988.

S. J. Watanabe-4 and . Takahashi-r, Determination of free and total 3-methoxy-4-hydroryphenylglycol in human plasma by HPLC with electrochemical detection, Clin. Chim. Acta, vol.152, pp.185-192, 1985.

S. P. Howell-j, HPLC method for determining plasma and urine 3-methoxy-4-hydroxyphenylglycol by amperometric detection, J Chromatogr. B, vol.306, pp.358-363, 1984.

S. J. and S. J. Wlls-mp, lmproved tiquid chromatographic determination of 3-methory-4-hydroxyphenylethyleneglycol in urine with electrochemical detection, Clin. Chem, vol.30, pp.140-143, 1984.

S. A. Sole-m and . R. Van-loon-g, Simultaneous measurement of S-hydroxytryptophan and L-Dihydrory phenylalanine by HPLC with electrochemical detection. Measurement of serotonin and catecholamine tumover in discrete brain regions, J. Chromatogr. B, vol.228, pp.123-130, 1982.

S. , .. H. Jones-g, and M. R. , Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake, Neuropharmacology, vol.17, pp.383-389, 1978.

S. , .. H. Rathbun-r, and . Kattau-r, Role of S-hydroxy tryptaminergic and adrenergic mechanism in antagonism of reserpine-induced hypothermia in mice, J. Pharm. Pharmacol, vol.31, pp.108-110, 1979.

S. P. Hardison-c, A review of multicentre controlled studies of fluoxetine versus imipramine and placebo in out patients with major depressive disorder, J. Clin. Psychiatry, vol.46, pp.53-58, 1985.

T. P. Boullin-d and . L. Davies-c, Simplified determination of serotonin in plasma by liquid chromatography with electrochemical detection, 1984.

T. M. Hamon-m, Un agent multiple: la sérotonine, Pour la Science, vol.221, pp.82-89, 1996.

T. L. and A. M. Bertilsson-l, Plasma levels of chlorimipramine and its desmethylmetabolite during treatment of depression, 1979.

T. J. and D. M. Mahuzier-g, Séparation des antidépresseurs polycycliques et de leurs principaux metabolites par chromatographie en phase liquide à polarité de phase inversée, Analusis; vol, vol.11, pp.278-283, 1983.

T. H. Hayashi-t and . Tatsumi-m, HPLC analysis for serotonin and tryptamine excreted in urine after oral loading with L-tryptophan, Ctin. Chem, vol.35, p.4347, 1989.

V. M. Lancon-c and . Bougerol-t, Caractérisation préliminaire du MHPG plasmatique total dans la depression, J. Psychiat. Biol. Ther, vol.27, pp.5-11, 1987.

V. Praag, H. M. Korf-j, and P. J. , 5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid, Nature, vol.114, issue.5239, pp.1259-1260, 1970.
DOI : 10.1055/s-0028-1094243

P. H. Van, . Korf-j, L. C. Dols, and T. Schut, A pirot study of the value of the probenecid test in application of the 5 HTP as antidepressant, 19721.

V. Praag, H. M. Korf-j, and . Schut-d, Cerebral monoamines and depression. An investigation with the probenecid technique, Psychopharmacologia ; Arch. Gen. Psychiatry, vol.2528, issue.1, pp.14-21, 1973.

V. Praag, H. M. Korf, J. M. Van-praag-h, and . Korf-j, 5-HYDROXYTRYPTOPHAN AS AN ANTIDEPRESSANT, The Journal of Nervous and Mental Disease, vol.158, issue.5, pp.331-337, 1974.
DOI : 10.1097/00005053-197405000-00004

V. Praag and H. M. , New evidence of serotonin deficient depressions, 19771.

V. Praag and H. M. Dehann-s, Central serotonin metabolism and frequency of depression, Psychiatry Research, vol.1, issue.3, pp.219-224, 1979.
DOI : 10.1016/0165-1781(79)90002-7

V. Praag and H. M. , Management of depression with serotonin precursors, Biol. Psychiat, vol.16, pp.291-310, 1981.

. Varoquaux-o, . Morin-d, and . Pays-m, Dosage de ta sérotonine libre et totale dans le plasma et le sérum par CLHP-EC, Ann. Biol. Ctin, vol.46, pp.576-587, 1988.

W. J. , D. S. , and D. 8. Zerbe-rl, FiXEd dose fluoxetine therapy for depression, Psychopharmacol. Bull, vol.23, pp.1-168, 1987.

D. T. Wong, H. P. Bymaster-f, and . B. Molloy-b, A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluorométhyl phénoxy)-N-méthyl-3-phényl propylamine A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(ptrifluoromethyf phenoxy)-N-methyl-3-phenyl propylamine, Life Sci. J. Pharmaae\. Exp. Ther, vol.1, issue.193, pp.471479804-811, 1975.

W. D. Bymaster-f, Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine, Res. Commun. Chem. Pathol, 1981.

W. D. , R. L. Bymaster-f, and . G. Threlkeld-p, Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors, J. Neural Transm, vol.64, pp.251-269, 1985.